Literature DB >> 29232521

Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.

Du-San Baek1, Jeong-Ho Kim1, Ye-Jin Kim1, Yong-Sung Kim1.   

Abstract

Neuropilin-1 (NRP1), which functions as a coreceptor for vascular endothelial growth factor (VEGF) and is implicated in vascular permeability and tumorigenesis, has been targeted by peptides that specifically bind to the VEGF-binding region on NRP1. Like natural VEGF ligands, all known peptides with NRP1-binding activity bind only through a carboxy (C)-terminal R/K-x-x-R/K sequence motif (x stands for any amino acids); this strict requirement is called the C-end rule (CendR). Here, we report immunoglobulin Fc-fused NRP1-specific peptides deviating from CendR. We screened a yeast surface-displayed Fc-fused non-CendR peptide library against NRP1 and isolated Fc-V12, wherein V12 peptide comprising 12 amino acids has a PPRV sequence at its C-terminal end. Although Fc-V12 lacked the CendR motif, it showed selective binding to the VEGF-binding region of NRP1 and triggered cellular internalization of NRP1, which resulted in enhanced extravasation into tumor tissues and tumor tissue penetration of the Fc-fused peptide along with the coinjected chemical drug in tumor-bearing mice. Through a saturation mutagenesis study, we identified that the Val residue at the C-terminus of Fc-V12 is crucial for NRP1 binding. We further improved NRP1 affinity of Fc-V12 (KD = ∼761 nM) through directed evolution of the upstream sequence of PPRV to obtain Fc-V12-33 (KD = ∼17.4 nM), which exhibited enhanced NRP1-mediated vascular permeability as compared with Fc-V12. Our results provide functional Fc-fused non-CendR peptides, which bind to the VEGF-binding region of NRP1 and enhance vascular permeability, expanding the sequence space of NRP1-targeting peptides.

Entities:  

Keywords:  C-end rule; neuropilin-1; peptide engineering; vascular permeability; yeast surface display

Mesh:

Substances:

Year:  2017        PMID: 29232521     DOI: 10.1021/acs.molpharmaceut.7b00761

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  3 in total

1.  Yeast Mating as a Tool for Highly Effective Discovery and Engineering of Antibodies via Display Methodologies.

Authors:  Du-San Baek; Seong-Wook Park; Cynthia Adams; Dimiter S Dimitrov; Yong-Sung Kim
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Neuropilins in the Context of Tumor Vasculature.

Authors:  Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

3.  Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity.

Authors:  Jung-Eun Kim; Keunok Jung; Jeong-Ah Kim; Seung-Hyun Kim; Hae-Sim Park; Yong-Sung Kim
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.